Medunik USA

Jul 22, 2025

Medunik USA expands Siklos® (hydroxyurea) coverage under Medicaid Programs to 37 states

Sep 17, 2024

Medunik USA expands Medicaid coverage and patient support services for Pheburane® (sodium phenylbutyrate)

Jun 04, 2024

Medunik USA's UNIK Support Program for Pheburane® expands to now include 2 specialty pharmacy options

Jan 23, 2024

Pheburane® (sodium phenylbutyrate) is now on the Medicaid Preferred Drug List in 10 states

Oct 19, 2020

Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in 100 mg scored tablets to help further optimize dosing